Shockwave Medical projects revenue for the full year 2023 to range from $660 million to $680 million, which represents growth of approximately 35% to 39% over 2022.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SWAV:
- Shockwave Medical Announces Agreement to Acquire Neovasc
- Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
- ShockWave selloff presents buying opportunity, says Piper Sandler
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- Wells Fargo cuts ShockWave Medical to Equal Weight, sees growth runway priced in